Exome sequencing has shown the presence of additional driver mutations in PDE11A-associated cancers and, more importantly, that these additional driver mutations differ substantially from one cancer to another (e.g., the pattern of driver mutations [and other genomic events, such as methylation] observed in adrenal adenomas is extremely different from those seen in testicular cancer). This evidence concerns the gene PDE11A and adrenal cortex adenoma.